European Respiratory Society
|Agreement labeling||European Respiratory Society Read & Publish 2022-2023|
|Has the agreement been fully disclosed and published?||Yes|
|Agreement period||01/01/2022 – 12/31/2023|
|Consortia / Institution||Jisc|
Approximate range of annual corresponding author publications
|Comments on size/article output||Estimated 2020/2021 output|
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Agreement costs within the range of the previous spending level|
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|OA publishing is unlimited|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||Fully OA titles are included selectively|
|OA LICENSE||CC-BY mandatory|
||Original research articles
What is the approximate share of access related costs of the overall agreement?
|More than 50%|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Yes|
|WORKFLOW ASSESSMENT||Too early to assess|
|Comments on workflows||The practical implementation of the agreement will be assessed by Jisc throughout its term|
|OVERALL ASSESSMENT AND COMMENTS||The agreement allows unlimited access to and open access publishing of research articles in the society’s hybrid title with an option to include the OA titles. The price is based on current spend and publishing output.|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|